A study has shown that inexpensive nanoparticles can effectively inhibit PD-L1 in cancer cells in the lab and work as well as antibodies, providing a potential alternative immunotherapy.
Read the full article at: https://www.drugtargetreview.com/news/55521/nanoparticles-could-be-an-alternative-to-antibody-immunotherapies/